1 / 14

Service de cardiologie, Hôpital universitaire nord, Marseille; FRANCE

Adjusted Clopidogrel Loading Doses According to VASP Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel low response: A Multicentre Randomized Prospective Study. Service de cardiologie, Hôpital universitaire nord, Marseille; FRANCE

allie
Download Presentation

Service de cardiologie, Hôpital universitaire nord, Marseille; FRANCE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adjusted Clopidogrel Loading Doses According to VASP Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel low response: A Multicentre Randomized Prospective Study. Service de cardiologie, Hôpital universitaire nord, Marseille; FRANCE Laboratoire d’hématologie, INSERM UMRS 608, Hôpital conception; Marseille; FRANCE Service de cardiologie, Hôpital d’aubagne, Aubagne; FRANCE Service de cardiologie, Clinique clairval, Marseille; FRANCE Service de cardiologie, Clinique Bouchard, Marseille; FRANCE Service de cardiologie, Hôpital privé beauregard, Marseille; FRANCE Laboratoire de statistique, Faculté de la timone, Marseille; FRANCE Service de cardiologie, Polyclinique les Fleurs, Ollioules, FRANCE L Bonello, L Camoin-Jau, S Arques, C Boyer, D Panagides, O Wittenberg, MC Siméoni, P Barragan, F Dignat-George, F Paganelli.

  2. CONFLICT OF INTEREST • None for any author. • This study was supported by a grant from the federation francaise de cardiologie, Paris, France.

  3. BACKGROUND Large inter-individual variability in response to clopidogrel has been observed when a 300 mg loading dose (LD) is used. A 600 mg LD decrease the mean platelet reactivity (PR) but does not overcome the large inter-individual variability observed. In press EHJ 2008

  4. Link between low response and stent thrombosis / ischemic events

  5. VASP index P2Y12 ADP-receptor - + PGE1 PGI2 ADP AC cAMP VASP index : standardized and reproducible. Highly specificof the response to clopidogrel. PKA VASP-P VASP GP 2b/3a complex Fibrinogen binding Activated platelets Inactivated Platelets Horstrup et al. Eur J Biochem 1994;225:21-7 Geiger et al. Arterioscler Thromb Vasc Biol. 1999;19:2007-11.

  6. DEFINITION OF LOW-RESPONSE using VASP index The negative predictive value of the VASP index to predict MACE after PCI was 100% using the cut-off value of 50% of PR. Therefore we defined low response as a post- treatment platelet reactivity ≥ 50% using the VASP index in the present study. Bonello L, et al. J Thromb Haemost. 2007;5:1630-6

  7. AIM • Clinical impact of loading dose adjustment according to platelet monitoring in patients with low-response to clopidogrel.

  8. STUDY DESIGN Non-emergent PCI : ACS and Stable angina (n=406) Loading dose (LD) ASA 250mg Clopidogrel 600mg VASP ≥ 50% Randomization (n=162) CONTROL (n=84) VASP-guided LD (n=78) Up-to 3 additional LD of 600 mg every 24 hours until VASP < 50% before PCI Maintenance dose ASA 160 mg Clopidogrel 75 mg 1° endpoint: MACE (CV death, MI, revascularization) at 30 days 2° endpoints: TIMI major and minor bleeding at 30 days

  9. BASELINE CHARACTERITICS

  10. PROCEDURAL CHARACTERISTICS

  11. PLATELET MONITORING -Each additionnal bolus of 600 mg of clopidogrel decreased the number of patients with low response from 35 to 49%. -Despite 2400 mg of clopidogrel 11 (14%) patients remained low-responders.

  12. PRIMARY-END POINT : EFFICACY Log rank p =0.007 MACE: CV death, MI, revascularization † p =0.059 * p =0.007

  13. BLEEDING Using additionnal clopidogrel LD in patients with low-response and according to platelet monitoring was safe.

  14. CONCLUSION • Adjusted loading dose of clopidogrel according to platelet monitoring using VASP assay is: • Feasible, safe • Efficacious in reducing post-PCI MACE. • Reaching a post-treatment platelet reactivity <50% using the VASP index seems optimal to prevent MACE in patients.

More Related